Key Highlights
•
The global supply of oral cholera vaccine is now adequate, allowing preventive vaccination campaigns to restart for the first time in over three years. This is a major step forward in controlling cholera outbreaks in vulnerable regions worldwide.
Source →
•
Researchers have developed a clear, step-by-step plan for implementing Endoscopic Sleeve Gastroplasty (ESG), a minimally invasive weight-loss procedure, within the UK’s National Health Service. This framework addresses key needs like training, patient selection, and support services, making this effective obesity treatment more accessible.
Source →
•
A study found that certain inherited mutations in a digestive enzyme can make symptoms worse for people with irritable bowel syndrome (IBS). This discovery helps explain why some people with IBS struggle to digest certain sugars and points to potential targets for future treatments.
Source →
•
A review article examines the current drug treatments for fatty liver disease, specifically in patients who also have type 2 diabetes. This is crucial because managing both conditions together is a common and complex challenge for doctors and patients.
Source →
•
Scientists discovered that the nerves connecting to the liver during early development control the body’s growth by regulating a key growth hormone. When this nerve connection is faulty, it can lead to fatty liver disease and impaired growth, revealing a new link between the nervous system and metabolism.
Source →
Stay curious. Stay informed — with
Science Briefing.
Always double check the original article for accuracy.
